生命科学资讯

Veradermics CEO has a great hair day with 122% pop in IPO

#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial

Bristol Myers draws pipeline excitement as several data readouts near

GLP-1s and the Super Bowl

Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex

Telehealth provider Hims goes after Novo's weight loss pill with compounded version

Eikon IPO analysis: Big biotech names, big valuation cut

FTC settles insulin lawsuit with Express Scripts

AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira

Rare pediatric PRV program reauthorized until 2029 via government funding law

GSK’s new CEO eyes more dealmaking, intense pipeline inspection

Veradermics lands $256M IPO for oral Rogaine

Midi Health raises $100M as it plans expansion into urgent care, research

Hims adds Grail's cancer test amid questions about widespread use

Novartis says generics to erode $4B from 2026 sales

Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio

FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug

UK’s health department expected to spend £1B in pharma trade deal with US

Novo expects sales to fall in 2026, triggering selloff

'Turning around the Titanic': How the incoming PBM reforms will transform CMS